clorazepate dipotassium

Generic: clorazepate dipotassium

Labeler: northstar rx llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clorazepate dipotassium
Generic Name clorazepate dipotassium
Labeler northstar rx llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

clorazepate dipotassium 15 mg/1

Manufacturer
NORTHSTAR RX LLC

Identifiers & Regulatory

Product NDC 72603-114
Product ID 72603-114_258be954-8e31-2be4-e063-6394a90a78ca
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075731
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2022-10-24

Pharmacologic Class

Classes
benzodiazepine [epc] benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72603114
Hyphenated Format 72603-114

Supplemental Identifiers

RxCUI
197464 197465 197466
UNII
63FN7G03XY

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clorazepate dipotassium (source: ndc)
Generic Name clorazepate dipotassium (source: ndc)
Application Number ANDA075731 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 15 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (72603-114-01)
source: ndc

Packages (1)

72603-114-01 100 TABLET in 1 BOTTLE (72603-114-01)

Ingredients (1)

clorazepate dipotassium (15 mg/1)

Linked Drug Pages (1)

Clorazepate Dipotassium ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "258be954-8e31-2be4-e063-6394a90a78ca", "openfda": {"unii": ["63FN7G03XY"], "rxcui": ["197464", "197465", "197466"], "spl_set_id": ["fb5c9e98-02b2-4c36-b436-25b58fe3c7d5"], "manufacturer_name": ["NORTHSTAR RX LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (72603-114-01)", "package_ndc": "72603-114-01", "marketing_start_date": "20221024"}], "brand_name": "Clorazepate Dipotassium", "product_id": "72603-114_258be954-8e31-2be4-e063-6394a90a78ca", "dosage_form": "TABLET", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "72603-114", "dea_schedule": "CIV", "generic_name": "Clorazepate Dipotassium", "labeler_name": "NORTHSTAR RX LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clorazepate Dipotassium", "active_ingredients": [{"name": "CLORAZEPATE DIPOTASSIUM", "strength": "15 mg/1"}], "application_number": "ANDA075731", "marketing_category": "ANDA", "marketing_start_date": "20221024", "listing_expiration_date": "20261231"}